Name (Synonyms) | Correlation | |
---|---|---|
drug1222 | Interferon beta-1b Wiki | 1.00 |
drug2434 | TRV027 Wiki | 1.00 |
drug3003 | sodium chloride 0.9% Wiki | 1.00 |
There is one clinical trial.
To conduct an open-label randomized controlled trial on a short course of interferon β-1b and clofazimine combination treatment for patients hospitalized for COVID-19 infection. To assess its safety and clinical efficacy.
Description: Time to complete alleviation of symptoms as defined by NEWS of 0 maintained for 24 hours
Measure: Clinical alleviation of symptoms Time: 7 daysDescription: Length of hospitalisation
Measure: Hospitalisation Time: 14 daysDescription: Time to negative nasopharyngeal swab, throat saliva and sputum viral load by RT-PCR
Measure: Time to negative viral load Time: 7 daysDescription: Cytokine/ chemokine changes
Measure: Inflammatory changes Time: 7 daysDescription: One month mortality rate
Measure: Mortality Time: 30 daysDescription: Adverse events during and shortly after treatment
Measure: Adverse events Time: 30 days